Meet the participants!
- IS Instruments
After a comprehensive selection phase, we are very pleased to present the participants!
Why we participate?!
Collaborative Life-Sciences and Bio-process
Testa Challenge welcome all kind of innovative solutions that have the potential to meet the future technology needs and challenges within bio-production.
Some examples in the area of technology include sensors, separation technology, pumps, etc. Within the digital/data segment, some examples include cloud solutions, VR / AR, AI, data transfer, modeling, smart automation, smart laboratory tools, new tools to monitor the quality processes, etc.
The proposed project can be a solution for any stage in the bio-process workflow, from preparation and planning, to the actual culture, harvest and downstream activities such as separation and purification.
After the challenge the participants will have reduced product development risks for their innovations by having verified their concepts. This in-turn with enable other investments on the participants journeys towards market introduction.
The goal is that the activities brought to the participants by the Testa Challenge shall make an evident difference in the development stage and the value of the participants projects.
Questions? Do not hesitate to contact us!
Helena Ströberg, Innovation coach
P: +46 725 77 04 51
Kristin Hellman, Innovation coach
P: +46 702 56 58 83
Maximilian Liedtke, Account Manager
P: +44 7827981505
You can also visit
About Testa Center
Testa Center is a non-profit company owned by Cytiva (formerly GE Healthcare Life Sciences). Testa Center is a major initiative between the Swedish government and Cytiva to secure the growth of life science industry and its manufacturing capabilities. Main objective for Testa Center is to bridge the gap from discovery to industrialization.
We offer businesses and academia globally a modern, pilot-scale testbed for projects and education in production of biological products e.g. monoclonal antibodies, peptides, protein, vaccine and viral vectors (non-GMP, up to Bio-safety level 2 and 500 liter).
In our flexible facility, and with some helping hands of our experienced staff, you can perform a wide variety of projects, including scale-up of parts of a process, or a complete process from frozen cell bank vial to purified protein.
We are a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. We are nearly 7000 associates with operations in 40 countries. We are a trusted partner to customers who do things ranging from fundamental biological research to making life-saving vaccines, biologic drugs and novel cell and gene therapies. Some of our customers use our products in industries outside of biological research.
Our vision is a world in which access to life-changing therapies transforms human health. Our everyday work leads us step by step toward this vision.
Our mission is advancing and accelerating therapeutics. We supply the tools and services – the pots, pans, soups and sauces - that help our customers do their work better, faster, and safer. Some of our products, such as filters, can also support a range of applications in industries outside of biological research. Everything we do is essential to the entire process – from start to finish and in between. We advance the work of our customers for better patient outcomes.
About STUNS Life Sciences
We foster expansion and connect people. As a fast-moving independent player in the regional and national life science ecosystem, STUNS Life Science is uniquely positioned to address both small and large life science company needs. With a diverse and highly competent team, a huge network, and a leading role in strategic life science programmes, we respond and act quickly.
About Agilent Technologies
A global leader in life sciences, diagnostics and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.
About Gyros Protein Technologies (Gyrolab®)
Gyrolab® technology delivers high-quality immunoassay data with broad dynamic ranges that enables conserving time, sample and reagents. Using an affinity flow-through format, Gyrolab technology simplifies immunoassay workflows by eliminating incubations and shortening run times. Our proprietary CD technology is engineered with highly reproducible nanoliter microfluidics integrated with Gyrolab platforms, which automate immunoassays with parallel assay processing and laser-induced fluorescence detection. The precise, automated control of centrifugal and capillary forces steer liquid flow through nanoliter-scale microfluidic structures contained within the CD in which the assay workflow is automated. For laboratories of all sizes, and research in any stage of discovery or development, Gyrolab® technology reduces manual labor, run time and material consumption, enhancing workflow efficiency.